Ind-Swift Laboratories board meeting scheduled for May 28, 2026 to approve audited financial results for Q4 and FY ending March 31, 2026.
The meeting notice is issued pursuant to SEBI LODR Regulation 29(1)(a) for considering standalone and consolidated results.
Trading window closure was previously communicated to exchanges via letter dated March 31, 2026 and information is available on company website.